Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombin III deficiency: clinical aspects.

I Nagy

    Haematologia
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Antithrombin III (AT-III) deficiency causes early, serious venous thromboembolism. Diagnosis requires multiple methods, and treatment involves lifelong coumarin therapy, with heparin requiring AT-III substitution during pregnancy or surgery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Short communication: The importance of random effects in detecting purging of inbreeding depression: A model comparison in Pannon White rabbits.

    Animal : an international journal of animal bioscience·2025
    Same author

    Transcriptional reprogramming post-peripheral nerve injury: A systematic review.

    Neurobiology of disease·2024
    Same author

    Effect of ambient temperature on the productive and carcass traits of growing rabbits divergently selected for body fat content.

    Animal : an international journal of animal bioscience·2021
    Same author

    Fungal Planet description sheets: 558-624.

    Persoonia·2017
    Same author

    Early solid additional feeding of suckling rabbits from 3 to 15 days of age.

    Animal : an international journal of animal bioscience·2017
    Same author

    Performance and welfare of rabbit does in various caging systems.

    Animal : an international journal of animal bioscience·2015
    Same journal

    The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.

    Haematologia·2003
    Same journal

    Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.

    Haematologia·2003
    Same journal

    Congenital methemoglobinemia due to NADH-methemoglobin reductase deficiency in three Indian families.

    Haematologia·2003
    Same journal

    Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.

    Haematologia·2003
    Same journal

    Vena cava superior syndrome due to sternal plasmacytoma in the course of systemic myeloma.

    Haematologia·2003
    Same journal

    Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.

    Haematologia·2003
    See all related articles

    Area of Science:

    • Hematology
    • Genetics
    • Clinical Medicine

    Background:

    • Antithrombin III (AT-III) deficiency is an inherited disorder.
    • It presents with early and severe venous thromboembolism.
    • Autosomal dominant inheritance patterns are observed.

    Purpose of the Study:

    • To outline the clinical manifestations of AT-III deficiency.
    • To detail diagnostic approaches for AT-III defects.
    • To describe management strategies for thromboembolic episodes in AT-III deficient patients.

    Main Methods:

    • Diagnosis involves immunological, amidolytic, and electrophoretic methods.
    • Identification of different types of AT-III defects.
    • Monitoring AT-III activity during treatment.

    Related Experiment Videos

    Main Results:

    • Clinical signs are precipitated by infections, trauma, and pregnancy.
    • AT-III defects include decreased amount/function, functional decrease, or altered heparin binding.
    • Decreased AT-III activity can fluctuate during treatment, offering diagnostic insights.

    Conclusions:

    • Lifelong coumarin therapy is standard for thromboembolic episodes.
    • Heparin use in pregnancy/post-surgery necessitates AT-III substitution.
    • Understanding AT-III deficiency is crucial for managing thrombotic risks.